Skip to content

Lung transplantation after allogeneic hematopoietic stem cell transplantation: a study from the Transplant Complications Working Party of the EBMT.

Oct 2026 · Bone Marrow Transplantation · 0 citations · 28 references
Medicine

TL;DR

LT is a feasible option for selected patients with end-stage LONIPCs, with long-term survival comparable to that reported for LT performed for other indications, and HLA-mismatched donor transplantation and corticosteroid use at LT were associated with inferior survival.

View source

Similar papers

Open access Oct 2026

Hematopoietic Cell Transplantation in Children with Sickle Cell Disease: A Single-Center Experience and Exploration of an Age Threshold for Post-Transplant Complications

Background/Objectives: Hematopoietic cell transplantation (HCT) is the only established curative option for sickle cell disease (SCD), yet the optimal timing in pediatric cohorts remains incompletely defined. Methods: We retrospectively analyzed all patients under 20 years with SCD who underwent HCT at the University H...

C. Nazon, Chloé Gerber, Alexandra Salmon et al. · 0 citations
Review Open access Sep 2026

Secondary failure of platelet recovery after allogeneic hematopoietic stem cell transplantation in pediatric acquired aplastic anemia: Incidence, risk factors, and clinical outcomes

Secondary failure of platelet recovery (SFPR) poses a significant risk for life-threatening complications following hematopoietic stem cell transplantation (HSCT). However, the incidence, clinical outcomes, and risk factors associated with SFPR in the context of allogeneic HSCT (allo-HSCT) for pediatric patients with a...

Yue Shang, Yuan-Yuan Ren, Li-Peng Liu et al. · 0 citations
Open access Sep 2026

Lung cancer after allogeneic hematopoietic stem cell transplantation.

INTRODUCTION Long-term outcomes of allogeneic hematopoietic cell transplantation (HCT) are improving, increasing the relevance of secondary malignancies, including lung cancer. The clinical utility of immune checkpoint inhibitors (ICIs) in this setting remains unclear and concerns regarding graft-versus-host disease (G...

M. Rost, C. Wehr, Miriam Mozaffari Jovein et al. · 0 citations
Open access Oct 2026

Overcoming Primary Graft Failure in Pediatric Allogeneic HSCT: Insights from Ten Centers of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC).

BACKGROUND Allogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative therapy for malignant and non-malignant diseases; however, primary graft failure (GF) is a life-threatening complication, particularly with the increasing use of alternative donors and reduced-intensity conditioning (RIC) str...

M. Daniel, Melissa Panesso Romero, María Isabel Benítez Carabante et al. · 0 citations
Oct 2026

Immunosuppression and Long-term Survival After Single Living-donor Lobar Lung Transplantation From the Same Donor as Prior Hematopoietic Stem Cell Transplantation: An All-Japan Study.

BACKGROUND Single living-donor lobar lung transplantation (LDLLT) from the same donor as prior hematopoietic stem cell transplantation (HSCT) represents a unique immunologic setting because of donor-cell chimerism. However, data regarding immunosuppressive management and long-term outcomes in this setting remain limite...

Tatsuaki Watanabe, T. Hirama, Tsuyoshi Ryuko et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.